| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18 |
| filingDate |
2000-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d90acede039f227b12b75957701df1fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_730e36311f3f84ef73e0ecc7228aca56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abbc7b2ff165a5365b04cd36a5c3ba48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be7c7e73cdfeee4bbe2c4ffef3b87dae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e991b1431ce7b9fe83cee76a13efef1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_440e5ba286fa21f32d40bfff54c499ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc349193cbee4ac848fb04103a6f1934
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4de517324c3125e61903f91d2aaea124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ad513ec545e2bb74c674211f09ada50 |
| publicationDate |
2003-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6593083-B1 |
| titleOfInvention |
Hepatitis C assay utilizing recombinant antigens |
| abstract |
Unique recombinant antigens representing distinct antigenic regions of the Hepatitis C Virus (HCV) genome which can be used as reagents for the detection of antibodies and antigen in body fluids from individuals exposed to HCV. The present invention also provides an assay for detecting the presence of an antibody to an HCV antigen in a sample by contacting the sample with the recombinant antigens. Preferred assay formats include a screening assay, a confirmatory assay, a competition or neutralization assay and an immunodot assay. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011152793-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003198644-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011002931-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011002936-A2 |
| priorityDate |
1990-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |